|
|
Volumn 17, Issue 2, 1998, Pages 133-140
|
|
Cutaneous T-cell lymphoma: Centuries of controversy
a
a
a
500 LCI
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL RESPONSE MODIFIER;
CARMUSTINE;
CHLORMETHINE;
INTERLEUKIN 2;
RETINOID;
CANCER CHEMOTHERAPY;
CANCER CLASSIFICATION;
CELLULAR IMMUNITY;
HISTOPATHOLOGY;
IMMUNOPHENOTYPING;
MOLECULAR DYNAMICS;
MULTIMODALITY CANCER THERAPY;
MYCOSIS FUNGOIDES;
PATHOGENESIS;
PUVA;
REVIEW;
T CELL LYMPHOMA;
TOPICAL DRUG ADMINISTRATION;
TREATMENT INDICATION;
BIOLOGICAL RESPONSE MODIFIERS;
DIAGNOSIS, DIFFERENTIAL;
DRUG THERAPY;
FEMALE;
HUMANS;
LYMPHOMA, T-CELL, CUTANEOUS;
MALE;
MYCOSIS FUNGOIDES;
NEOPLASM STAGING;
PROGNOSIS;
PUVA THERAPY;
REMISSION INDUCTION;
RISK FACTORS;
SKIN NEOPLASMS;
|
|
EID: 0031866427
PISSN: 10855629
EISSN: None
Source Type: Journal
DOI: 10.1016/S1085-5629(98)80006-0 Document Type: Review |
|
Times cited : (5)
|
|
References (34)
|
